The precise role of residues 91–106 in the conversion of PrPC into PrPSc would be helpful not just to improve our understanding of the mechanism underlying the conversion of PrPC into PrPSc but also for the development of therapeutic agents in prion diseases. The gene discussed is PRNP; the disease is prion disease.